1082: Analysis of Candidate SNPs in Prostate Cancer Cases and Disease Free Controls
James K. Burmester(Marshfield Clinic), William J. Catàlona(Northwestern University), Kai-Qi Zhang, Brian K. Suarez(Washington University in St. Louis), Raymond D. Miller(Washington University in St. Louis), Jennifer Y. Lin(Harvard University), Douglas J. Reding(Ascension), Carol H Jin, Sherry A. Salzman(Cancer Genetics (United States))
Cited by 0
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996